back to top
- Immunotherapy in Multiple Myeloma: The Era of CAR T Cell TherapyApril 02, 2018 | May-June 2018, Volume 15, Issue 3
Dr. Ghobrial and Dr. Mouhieddine discuss the field of immunotherapy in multiple myeloma, specifically the use of CAR T cell therapy.
- When Does Monoclonal Gammopathy Acquire Significance?February 08, 2018 | March-April 2018, Volume 15, Issue 2
Drs. Bustoros, Liu, Sklavenitis-Pistofidis, and Ghobrial look at studies by Dr. Robert Kyle that have transformed the landscape of precursor conditions is plasma cell malignancies and cancer, specifically the understanding of MGUS.
- Exosomes in Hematologic MalignanciesMarch 01, 2014 | March-April 2014, Volume 11, Issue 2
Dr. Aldo Roccaro,
Dr. Salomon Manier, and Dr. Irene
Ghobrial review the diverse ways in
which exosomes contribute to the
pathophysiology of multiple myeloma,
acute leukemia, and B-cell lymphoma.
- Similar Dreams, Different JourneysNovember 01, 2011 | November-December 2011, Volume 8, Issue 6
As the 10-year anniversary of the Clinical Research Training Institute approaches, ASH highlights two early participants. Dr. Ghobrial participated in 2003 (the inaugural year), and Dr. Blum participated in 2004.
Dr. Ghobrial is Associate Professor of Medicine at Harvard Medical School and Dana Farber Cancer Institute. She is Director of the Michele & Steven Kirsch Laboratory and of the Clinical Investigator Research Program at Dana Farber. Her research interests include multiple myeloma and Waldenstrom's macroglobulinemia.
Harvard Medical School; Dana Farber Cancer Institute